Neuro65/AOCN2024

Presentation information

Print

Oral Session

English

[O-02] Oral Session 02 ［English］「Gene therapy, Regenerative medicine, and Therapy development」

Wed. May 29, 2024 3:35 PM - 5:05 PM Room6 (Hall D7, D Block, 7F, TIF)

Chair(s): Tetsuya Nagata (NucleoTIDE and PepTIDE Drug Discovery Center, Tokyo Medical and Dental University, Japan), Yohei Okada (Institute for Medical Science of Aging, Aichi Medical University, Japan)

[O-02-2] Chemical modification reduces neurotoxicity of intrathecally injected antisense oligonucleotide

Takayuki Kuroda1, Kotaro Yoshioka1, Su Lei Mon Su1, Kumiko Sato1, Eriko Isogai1, Maho Katsuyama1, Kie Yoshida-tanaka1, Rintaro Iwata-Hara1, Takao Yamaguchi2, Tetsuya Nagata1, Satoshi Obika2, Takanori Yokota1 (1.Department of Neurology and Neurological Science, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Japan, 2.Bioorganic Chemistry, Graduate School of Pharmaceutical Sciences, Osaka University, Japan)

Abstract password authentication.
You can find the password on page 15 of the program book.

Password